Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Lalli

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Seizure|September 19, 2025
Prediction of evolution to epilepsy or genetic epilepsy with febrile seizures plus (GEFS+) in children presenting with febrile seizures: a retrospective multicenter longitudinal studyPietro Baso, Silvia Masnada, Monica Maria Lodi, et al.
Head & Neck|March 5, 2026
Different Pattern of Treatment Failure After Chemoradiation Between p16+ and p16- Patients Affected by Oropharyngeal CarcinomaRiccardo Gili, Paolo Bossi, Luca Lalli, et al.
Clinical and Translational Medicine|June 29, 2021
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patientsDarawan Rinchai, Elena Verzoni, Veronica Huber, et al.
Cancers|August 27, 2021
The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma PatientsGiovanni Paolino, Veronica Huber, Serena Camerini, et al.
Tumori|May 4, 2026
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinomaAlessandro Rametta, Sebastiano Buti, Marco Stellato, et al.
European Urology Open Science|October 27, 2025
Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24)Marco Stellato, Pierangela Sepe, Enrico Bronte, et al.
Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.
Clinical Genitourinary Cancer|April 17, 2024
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27Marco Stellato, Sebastiano Buti, Marco Maruzzo, et al.
The Journal of Investigative Dermatology|June 1, 2022
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional ProfilesElisabetta Vergani, Adele Busico, Matteo Dugo, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patientsVeronica Huber, Lorenza Di Guardo, Luca Lalli, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Seizure|September 19, 2025
Prediction of evolution to epilepsy or genetic epilepsy with febrile seizures plus (GEFS+) in children presenting with febrile seizures: a retrospective multicenter longitudinal studyPietro Baso, Silvia Masnada, Monica Maria Lodi, et al.
Head & Neck|March 5, 2026
Different Pattern of Treatment Failure After Chemoradiation Between p16+ and p16- Patients Affected by Oropharyngeal CarcinomaRiccardo Gili, Paolo Bossi, Luca Lalli, et al.
Clinical and Translational Medicine|June 29, 2021
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patientsDarawan Rinchai, Elena Verzoni, Veronica Huber, et al.
Cancers|August 27, 2021
The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma PatientsGiovanni Paolino, Veronica Huber, Serena Camerini, et al.
Tumori|May 4, 2026
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinomaAlessandro Rametta, Sebastiano Buti, Marco Stellato, et al.
European Urology Open Science|October 27, 2025
Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24)Marco Stellato, Pierangela Sepe, Enrico Bronte, et al.
Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.
Clinical Genitourinary Cancer|April 17, 2024
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27Marco Stellato, Sebastiano Buti, Marco Maruzzo, et al.
The Journal of Investigative Dermatology|June 1, 2022
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional ProfilesElisabetta Vergani, Adele Busico, Matteo Dugo, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patientsVeronica Huber, Lorenza Di Guardo, Luca Lalli, et al.
Pageof 5